Daedalus Biotech Advisors Information

Daedalus maintains an exhaustive, proprietary database covering both public and private firms as well as academic and government institutions worldwide, including drug development and diagnostics programs, technology, executives, finances, principal investors, and corporate histories. Our depth of executive experience and personal connections allow us to exploit this unique resource fully for the benefits of our clients; and, our concentration on the life sciences means that none of our talent, resources, or attention is drawn away from the opportunities and problems of drug development and diagnostics. We offer the entirety of our services to potential clients of all sizes tailoring them to suit the particular needs of the client with fee dependent on the size of the deal. Larger clients will find that because of our intense coverage and experience of the industry no one is better placed to assist in acquiring the drug candidates they seek as well find companies with the special technologies they wish to acquire. This coverage extends to lower cost drug research and development operations outside of the United States and Europe as well as a full range of services worldwide. To smaller firms Daedalus offers strategic business advice suitable to every stage of a firm's development, financial services with access to venture capital and private investment, IPO and public offering guidance, inlicensing drug candidates and outsourcing services across the board, research and development partnerships, and mergers and acquisitions. We arrange financing from the most promising startup, through tier financings and IPO's, drug development, commercialization, and even the ultimate sale of the company. By utilizing for its own clients the large and growing number of biotech firms and their drug candidates and resources, Daedalus helps them gain the necessary edge over competitors. To private investors we offer the specialized advice an investment in the life sciences field requires.